Recent Finacing
Recent Raise
Tioga Pharmaceuticals develops GI therapies, advancing oral asimadoline for D-IBS in a Phase 3 SPA trial with FDA; rights outside Japan, South Korea and Taiwan retained.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors